Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Most popular cardiology video interviews this past month
Sunday, September 21, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Top Video Content

CCTA could make invasive angiography a thing of the past

John Puskas, MD, thinks coronary CT angiography is on its way to completely transforming patient care. 

READ MORE >
Cardiac surgeon John Puskas, MD, Emory University, says CCTA will make invasive angiography obsolete very soon.
Share on Twitter Share on Facebook Share on Linkedin

CCTA could make invasive angiography a thing of the past

Share on Twitter Share on Facebook Share on Linkedin
Cardiac surgeon John Puskas, MD, Emory University, says CCTA will make invasive angiography obsolete very soon.
John Puskas, MD, thinks coronary CT angiography is on its way to completely transforming patient care. 
READ MORE >

New device could make it easier than ever for cardiologists to perform BASILICA before TAVR

Toby Rogers, MD, PhD, noted that BASILICA is a fairly complex procedure. Using this advanced technology, however, could make it easier to perform and improve patient access.

READ MORE >
Toby Rogers, MD, Medstar, discusses a new dedicated device for BASILICA used in TAVR.
Share on Twitter Share on Facebook Share on Linkedin

New device could make it easier than ever for cardiologists to perform BASILICA before TAVR

Share on Twitter Share on Facebook Share on Linkedin
Toby Rogers, MD, Medstar, discusses a new dedicated device for BASILICA used in TAVR.
Toby Rogers, MD, PhD, noted that BASILICA is a fairly complex procedure. Using this advanced technology, however, could make it easier to perform and improve patient access.
READ MORE >

Lipoprotein(a) tests could transform patient care—is it time for universal screening?

"Lp(a) represents the most important potential potential paradigm shift in cardiovascular disease prevention that we'll experience over the next five to 10 years," Seth Baum, MD, explained in a new interview.

READ MORE >
Seth Baum, MD, FACC, FACPM, FAHA, FNLA, FASPC, Chairman of the Board for the Family Heart Foundation, past president of the American Society for Preventive Cardiology, clinical affiliate professor of biomedical science at Florida Atlantic University, and chief medical officer of Flourish Research, explains why testing for familial hypercholesterolemia (FH) and elevated Lipoprotein(a) could be critical to identify more patients with elevated risk of cardiac events, but have their LDL well controlled.
Share on Twitter Share on Facebook Share on Linkedin

Lipoprotein(a) tests could transform patient care—is it time for universal screening?

Share on Twitter Share on Facebook Share on Linkedin
Seth Baum, MD, FACC, FACPM, FAHA, FNLA, FASPC, Chairman of the Board for the Family Heart Foundation, past president of the American Society for Preventive Cardiology, clinical affiliate professor of biomedical science at Florida Atlantic University, and chief medical officer of Flourish Research, explains why testing for familial hypercholesterolemia (FH) and elevated Lipoprotein(a) could be critical to identify more patients with elevated risk of cardiac events, but have their LDL well controlled.
"Lp(a) represents the most important potential potential paradigm shift in cardiovascular disease prevention that we'll experience over the next five to 10 years," Seth Baum, MD, explained in a new interview.
READ MORE >

How to choose between CABG and PCI when treating coronary artery disease

John Puskas, MD, chief of cardiothoracic surgery at Emory University Hospital Midtown, noted that both treatment options have their own benefits. It often depends on the patient's age and comorbidities, though there are other factors to consider as well. 

READ MORE >
John D. Puskas, MD, MSc, PhD., FACS, FACC, professor of surgery, and chief of cardiothoracic surgery at Emory University Hospital Midtown, explains when patients are best served with coronary artery bypass graft (CABG) surgery rather than percutaneous coronary intervention (PCI).
Share on Twitter Share on Facebook Share on Linkedin

How to choose between CABG and PCI when treating coronary artery disease

Share on Twitter Share on Facebook Share on Linkedin
John D. Puskas, MD, MSc, PhD., FACS, FACC, professor of surgery, and chief of cardiothoracic surgery at Emory University Hospital Midtown, explains when patients are best served with coronary artery bypass graft (CABG) surgery rather than percutaneous coronary intervention (PCI).
John Puskas, MD, chief of cardiothoracic surgery at Emory University Hospital Midtown, noted that both treatment options have their own benefits. It often depends on the patient's age and comorbidities, though there are other factors to consider as well. 
READ MORE >

How interventional cardiologists can boost cardiac surgery volumes

Competition was once fierce between interventional cardiologists and cardiac surgeons, but that has changed over the years. "It is absolutely a partnership," one veteran surgeon told Cardiovascular Business. 

READ MORE >
John Puskas, MD, MSc, PhD., FACS, FACC, professor of surgery, and chief of cardiothoracic surgery at Emory University Hospital Midtown, explains how interventional cardiologists can play a role in increasing referrals for coronary artery bypass graft (CABG) surgery for patients who are best suited for the procedure, as opposed to percutaneous coronary intervention (PCI). As the heart team approach expands across cardiology, with surgeons and interventionalists making more decisions together.
Share on Twitter Share on Facebook Share on Linkedin

How interventional cardiologists can boost cardiac surgery volumes

Share on Twitter Share on Facebook Share on Linkedin
John Puskas, MD, MSc, PhD., FACS, FACC, professor of surgery, and chief of cardiothoracic surgery at Emory University Hospital Midtown, explains how interventional cardiologists can play a role in increasing referrals for coronary artery bypass graft (CABG) surgery for patients who are best suited for the procedure, as opposed to percutaneous coronary intervention (PCI). As the heart team approach expands across cardiology, with surgeons and interventionalists making more decisions together.
Competition was once fierce between interventional cardiologists and cardiac surgeons, but that has changed over the years. "It is absolutely a partnership," one veteran surgeon told Cardiovascular Business. 
READ MORE >

AI software takes cardiac risk assessments to another level

Allen Taylor, MD, thinks AI-powered plaque evaluations can make a substantial impact on patient care. 

READ MORE >
Video interview with Allen Taylor, MD, chairman of cardiology at Medstar, who explains use of AI CCTA plaque analysis at Medstar to improve risk assessments.
Share on Twitter Share on Facebook Share on Linkedin

AI software takes cardiac risk assessments to another level

Share on Twitter Share on Facebook Share on Linkedin
Video interview with Allen Taylor, MD, chairman of cardiology at Medstar, who explains use of AI CCTA plaque analysis at Medstar to improve risk assessments.
Allen Taylor, MD, thinks AI-powered plaque evaluations can make a substantial impact on patient care. 
READ MORE >

AI now embedded in nearly every cardiovascular IT system

Artificial intelligence's role in day-to-day patient care continues to grow. What should health systems and cardiology departments be thinking about as they shop for new technologies?

READ MORE >
Amy Thompson from Signify Research explains integration of AI into CVIS systems
Share on Twitter Share on Facebook Share on Linkedin

AI now embedded in nearly every cardiovascular IT system

Share on Twitter Share on Facebook Share on Linkedin
Amy Thompson from Signify Research explains integration of AI into CVIS systems
Artificial intelligence's role in day-to-day patient care continues to grow. What should health systems and cardiology departments be thinking about as they shop for new technologies?
READ MORE >

How economic forces are reshaping the future of cardiac care

Karen Joynt Maddox, MD, MPH, explained the many ways cardiology's business models are starting to evolve. She also touched on a number of other topics, including AI and the power of prevention.

READ MORE >
Karen Joynt Maddox discusses macroeconomic factors pressuring traditional models of cardiac care.
Share on Twitter Share on Facebook Share on Linkedin

How economic forces are reshaping the future of cardiac care

Share on Twitter Share on Facebook Share on Linkedin
Karen Joynt Maddox discusses macroeconomic factors pressuring traditional models of cardiac care.
Karen Joynt Maddox, MD, MPH, explained the many ways cardiology's business models are starting to evolve. She also touched on a number of other topics, including AI and the power of prevention.
READ MORE >

Successful outreach program brings heart screenings to underserved communities

Former ACC president Kim Allan Williams Sr., MD, shared his experience bringing helpful heart screenings to low-income neighborhoods. "You've got to be willing to go out and find where the patients are," he said. 

READ MORE >
Video with former ACC president Kim Williams, MD, discusses a heart screening outreach program he created in low-income Louisville neighborhoods.
Share on Twitter Share on Facebook Share on Linkedin

Successful outreach program brings heart screenings to underserved communities

Share on Twitter Share on Facebook Share on Linkedin
Video with former ACC president Kim Williams, MD, discusses a heart screening outreach program he created in low-income Louisville neighborhoods.
Former ACC president Kim Allan Williams Sr., MD, shared his experience bringing helpful heart screenings to low-income neighborhoods. "You've got to be willing to go out and find where the patients are," he said. 
READ MORE >

AHA data challenge explores links between inflammation and heart disease

Are care teams doing enough to take on inflammation? The American Heart Association hopes this new research initiative can help answer that question, and many others. 

READ MORE >
The American Heart Association (AHA) has launched a nationwide data-driven research competition to uncover how inflammation contributes to cardiovascular risk and how it is currently addressed in clinical practice. The initiative, called the Systemic Inflammation Data Challenge, invites data scientists, clinicians, and researchers to leverage advanced analytics and electronic medical record (EMR) data to better understand the impact of systemic inflammation on atherosclerotic cardiovascular disease.
Share on Twitter Share on Facebook Share on Linkedin

AHA data challenge explores links between inflammation and heart disease

Share on Twitter Share on Facebook Share on Linkedin
The American Heart Association (AHA) has launched a nationwide data-driven research competition to uncover how inflammation contributes to cardiovascular risk and how it is currently addressed in clinical practice. The initiative, called the Systemic Inflammation Data Challenge, invites data scientists, clinicians, and researchers to leverage advanced analytics and electronic medical record (EMR) data to better understand the impact of systemic inflammation on atherosclerotic cardiovascular disease.
Are care teams doing enough to take on inflammation? The American Heart Association hopes this new research initiative can help answer that question, and many others. 
READ MORE >

Cardiovascular IT systems keep evolving with AI, Epic integration on the rise

A Signify Research representative highlights key trends in cardiovascular IT systems, including the growing role of AI and much more. 

READ MORE >
Healthcare IT analyst Amy Thompson from Signify Research explains trends in cardiology information systems at ACC 2025.
Share on Twitter Share on Facebook Share on Linkedin

Cardiovascular IT systems keep evolving with AI, Epic integration on the rise

Share on Twitter Share on Facebook Share on Linkedin
Healthcare IT analyst Amy Thompson from Signify Research explains trends in cardiology information systems at ACC 2025.
A Signify Research representative highlights key trends in cardiovascular IT systems, including the growing role of AI and much more. 
READ MORE >

Interest rising in CKM syndrome as connections become clearer

Cardiovascular-kidney-metabolic (CKM) syndrome is a popular research topic among cardiologists, highlighting just how closely obesity, type 2 diabetes, chronic kidney disease and cardiovascular disease are related to one another. Joshua Joseph, MD, spoke to Cardiovascular Business about this ongoing trend.

READ MORE >
Joshua Joseph, MD, MPH, FAHA an expert in Cardiovascular-Kidney-Metabolic (CKM) syndrome, associate professor of internal medicine, and the Endowed Professor for Research in Internal Medicine in the Division of Endocrinology, Diabetes and Metabolism at The Ohio State University Wexner Medical Center, explains the CKM advisory from the American Heart Association designed to help define and stage the disease. CKM has seen a large amount of growing interest from cardiologists in recent years.
Share on Twitter Share on Facebook Share on Linkedin

Interest rising in CKM syndrome as connections become clearer

Share on Twitter Share on Facebook Share on Linkedin
Joshua Joseph, MD, MPH, FAHA an expert in Cardiovascular-Kidney-Metabolic (CKM) syndrome, associate professor of internal medicine, and the Endowed Professor for Research in Internal Medicine in the Division of Endocrinology, Diabetes and Metabolism at The Ohio State University Wexner Medical Center, explains the CKM advisory from the American Heart Association designed to help define and stage the disease. CKM has seen a large amount of growing interest from cardiologists in recent years.
Cardiovascular-kidney-metabolic (CKM) syndrome is a popular research topic among cardiologists, highlighting just how closely obesity, type 2 diabetes, chronic kidney disease and cardiovascular disease are related to one another. Joshua Joseph, MD, spoke to Cardiovascular Business about this ongoing trend.
READ MORE >

Cardiologist became paralyzed after wearing heavy aprons in the cath lab for decades—but he fought back

Dean J. Kereiakes, MD, was left paralyzed after battling severe orthopedic issues for his entire career. Back in the cath lab after a long recovery, he is now stressing the importance of workplace safety among interventional cardiologists.

READ MORE >
Dean Kereiakes, a nationally renowned interventional cardiologist and president of The Christ Hospital Heart and Vascular Institute, has long been recognized for his groundbreaking work in cardiovascular research and intervention. But in 2024, his career and his life were permanently altered when decades of wearing heavy lead protection in the cath lab left him paralyzed.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist became paralyzed after wearing heavy aprons in the cath lab for decades—but he fought back

Share on Twitter Share on Facebook Share on Linkedin
Dean Kereiakes, a nationally renowned interventional cardiologist and president of The Christ Hospital Heart and Vascular Institute, has long been recognized for his groundbreaking work in cardiovascular research and intervention. But in 2024, his career and his life were permanently altered when decades of wearing heavy lead protection in the cath lab left him paralyzed.
Dean J. Kereiakes, MD, was left paralyzed after battling severe orthopedic issues for his entire career. Back in the cath lab after a long recovery, he is now stressing the importance of workplace safety among interventional cardiologists.
READ MORE >

The power of prevention: Cardiologist says proactive patient care can make a big difference later in life

Former ACC president Kim Allan Williams Sr., MD, thinks cardiologists should be much more proactive. Encouraging healthy eating habits now, for example, can keep patients out of the hospital later in life and reduce healthcare spending.

READ MORE >
Former American College of Cardiology (ACC) president Kim Allan Williams, Sr., MD, MACC, MASNC, FAHA, FESC, chair, department of medicine, University of Louisville School of Medicine, and an ACC delegate to the American Medical Association House of Delegates, discusses how cardiology should be focusing more on earlier prevention efforts in cardiology.
Share on Twitter Share on Facebook Share on Linkedin

The power of prevention: Cardiologist says proactive patient care can make a big difference later in life

Share on Twitter Share on Facebook Share on Linkedin
Former American College of Cardiology (ACC) president Kim Allan Williams, Sr., MD, MACC, MASNC, FAHA, FESC, chair, department of medicine, University of Louisville School of Medicine, and an ACC delegate to the American Medical Association House of Delegates, discusses how cardiology should be focusing more on earlier prevention efforts in cardiology.
Former ACC president Kim Allan Williams Sr., MD, thinks cardiologists should be much more proactive. Encouraging healthy eating habits now, for example, can keep patients out of the hospital later in life and reduce healthcare spending.
READ MORE >

Can IVL help cardiologists treat mitral valve disease?

Jaffar Khan, MD, explained his team's work using intravascular lithotripsy balloons in a cadaver heart to break up mitral annular calcification. 

READ MORE >
Video interview with Jaffar Khan, MD, St. Francis Heart Center, explaining tests using IVL in mitral annular calcification (MAC).
Share on Twitter Share on Facebook Share on Linkedin

Can IVL help cardiologists treat mitral valve disease?

Share on Twitter Share on Facebook Share on Linkedin
Video interview with Jaffar Khan, MD, St. Francis Heart Center, explaining tests using IVL in mitral annular calcification (MAC).
Jaffar Khan, MD, explained his team's work using intravascular lithotripsy balloons in a cadaver heart to break up mitral annular calcification. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup